Human microdosing for the prediction of patient response

Por Henderson, Paul T, Pan, Chong-xian
Publicado em 2010

Progress in Personalizing Chemotherapy for Bladder Cancer

Por Chang, James S., Lara, Primo N., Pan, Chong-Xian
Publicado em 2012

Personalized medicine for targeted and platinum-based chemotherapy of lung and bladder cancer

Por Cimino, George D, Pan, Chong-xian, Henderson, Paul T
Publicado em 2013

Contemporary management of muscle-invasive bladder cancer

Por Dall’Era, Marc A, Cheng, Liang, Pan, Chong-Xian
Publicado em 2012

Evaluation of Protein Levels of the Receptor Tyrosine Kinase ErbB3 in Serum

Por D’Abronzo, Leandro S., Pan, Chong-Xian, Ghosh, Paramita M.
Publicado no Methods Mol Biol (2018)

Nanotechnology in bladder cancer: current state of development and clinical practice

Por Tomlinson, Ben, Lin, Tzu-yin, Dall'Era, Marc, Pan, Chong-Xian
Publicado no Nanomedicine (Lond) (2015)

Analysis of the Cytotoxic Activity of the Carboplatin and Gemcitabine Combination

Por Wang, Sisi, Zhang, Hongyong, Cheng, Liang, Evans, Christopher, Pan, Chong-Xian
Publicado no Anticancer Res (2010)

A Simple Three-Dimensional In Vitro Culture Mimicking the In Vivo-Like Cell Behavior of Bladder Patient-Derived Xenograft Models

Por Amaral, Robson, Zimmermann, Maike, Ma, Ai-Hong, Zhang, Hongyong, Swiech, Kamilla, Pan, Chong-Xian
Publicado no Cancers (Basel) (2020)

Preclinical models for bladder cancer research

Por Zhu, Shaoming, Zhu, Zheng, Ma, Ai-Hong, Sonpavde, Guru, Cheng, Fan, Pan, Chong-xian
Publicado no Hematol Oncol Clin North Am (2021)

Characterization of high-affinity peptides and their feasibility for use in nanotherapeutics targeting leukemia stem cells

Por Zhang, Hongyong, Luo, Juntao, Li, Yuanpei, Henderson, Paul T, Wachsmann-Hogiu, Sebastian, Lam, Kit S., Pan, Chong-xian
Publicado no Nanomedicine (2011)

Novel nanococktail of a dual PI3K/mTOR inhibitor and cabazitaxel for castration-resistant prostate cancer

Por Huang, Yee, Xue, Xiangdong, Li, Xiaocen, Jia, Bei, Pan, Chong-xian, Li, Yuanpei, Lin, Tzu-yin
Publicado no Adv Ther (Weinh) (2020)

Regulation of androgen receptor transcriptional activity by rapamycin in prostate cancer cell proliferation and survival

Por Wang, Yu, Mikhailova, Margarita, Bose, Swagata, Pan, Chong-Xian, deVere White, Ralph W., Ghosh, Paramita M.
Publicado em 2008

Feasibility Study of Intra-patient Sorafenib Dose-Escalation or Re-Escalation in Patients with Previously Treated Advanced Solid Tumors

Por Semrad, Thomas J., Eddings, Courtney, Pan, Chong-Xian, Lau, Derick H., Gandara, David, Beckett, Laurel, Lara, Primo N.
Publicado em 2011

Paclitaxel Enhances Carboplatin-DNA Adduct Formation and Cytotoxicity

Por Jiang, Shuai, Pan, Amy W., Lin, Tzu-yin, Zhang, Hongyong, Malfatti, Michael, Turteltaub, Kenneth, Henderson, Paul T., Pan, Chong-xian
Publicado no Chem Res Toxicol (2015)

Determinants of survival in adolescents and young adults with urothelial bladder cancer: results from the California Cancer Registry

Por Lara, Joshua, Brunson, Ann, Keegan, Theresa H.M., Malogolowkin, Marcio, Pan, Chong-Xian, Yap, Stanley, deVere White, Ralph
Publicado no J Urol (2016)

Toward Predicting Acute Myeloid Leukemia Patient Response to 7 + 3 Induction Chemotherapy via Diagnostic Microdosing

Por Scharadin, Tiffany M., Malfatti, Michael A., Haack, Kurt, Turteltaub, Kenneth W., Pan, Chong-xian, Henderson, Paul T., Jonas, Brian A.
Publicado no Chem Res Toxicol (2018)

Pembrolizumab Combined With Either Docetaxel or Gemcitabine in Patients With Advanced or Metastatic Platinum-Refractory Urothelial Cancer: Results From a Phase I Study

Por Parikh, Mamta, Pan, Chong-Xian, Beckett, Laurel A., Li, Yueju, Robles, Daniel A., Aujla, Pawandeep K., Lara, Primo N.
Publicado no Clin Genitourin Cancer (2018)

Gemcitabine causes minimal modulation of carboplatin-DNA monoadduct formation and repair in bladder cancer cells

Por Wang, Sisi, Zhang, Hongyong, Malfatti, Michael, de Vere White, Ralph, Lara, Primo N., Turteltaub, Kenneth, Henderson, Paul, Pan, Chong-xian
Publicado em 2010

Prospective Evaluation of Low-Dose Ketoconazole Plus Hydrocortisone (HC) in Docetaxel Pre-treated Castration-Resistant Prostate Cancer (CRPC) Patients

Por Lo, Ernest N., Beckett, Laurel A., Pan, Chong-Xian, Robles, Daniel, Suga, Jennifer M., Sands, Jacob M., Lara, Primo N.
Publicado no Prostate Cancer Prostatic Dis (2015)

Targeting canine bladder transitional cell carcinoma with a human bladder cancer-specific ligand

Por Lin, Tzu-yin, Zhang, Hongyong, Wang, Sisi, Xie, Li, Li, Bin, Rodriguez, Carlos O, de Vere White, Ralph, Pan, Chong-xian
Publicado em 2011